Genentech, Inc. Rises on Report of Higher Roche Buyout Bid

Jan. 9 (Bloomberg) -- Genentech Inc. rose 2.3 percent in New York trading on a Financial Times report that Swiss drugmaker Roche Holding AG is preparing to raise its bid for the biotechnology company to $95 a share.